Wuhan Hvsen Biotechnology Co.,Ltd. (SHE:300871)
China · Delayed Price · Currency is CNY 24.30
+0.05 (0.21%)
Jul 15, 2026, 3:04 PM CST
Wuhan Hvsen Biotechnology Market Cap
Wuhan Hvsen Biotechnology has a market cap or net worth of 4.89 billion as of July 14, 2026. Its market cap has increased by 18.30% in one year.
Market Cap
4.89B
Enterprise Value
4.64B
Revenue
1.74B
Ranking
n/a
PE Ratio
17.11
Stock Price
24.30
Market Cap Chart
Since August 24, 2020, Wuhan Hvsen Biotechnology's market cap has decreased from 6.83B to 4.89B, a decrease of -28.41%. That is a compound annual growth rate of -5.51%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 15, 2026 | 4.89B | 17.10% |
| Dec 31, 2025 | 4.18B | 151.73% |
| Dec 31, 2024 | 1.66B | -29.78% |
| Dec 29, 2023 | 2.36B | -29.56% |
| Dec 30, 2022 | 3.36B | -29.11% |
| Dec 31, 2021 | 4.73B | 7.30% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Aug 24, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novogene | 5.19B |
| Hangzhou Biotest Biotech | 5.08B |
| Zhejiang Wecome Pharmaceutical Company | 4.93B |
| R&G PharmaStudies | 4.91B |
| Shenzhen Weiguang Biological Products | 4.72B |
| Hefei Lifeon Pharmaceutical | 4.70B |
| Suzhou Fengbei Biotech Stock | 4.39B |
| ChemPartner PharmaTech | 4.30B |